- marketscreener.com quote/stock/ASTRAZENECA-PLC-…AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%).
- wikicorporates.org wiki/AstraZeneca_plc3.2 Zeneca Group plc. ... AstraZeneca plc: Zeneca Group plc and Sweden-based pharmaceutical company Astra AB merged.ref ref.
- tr.tradingview.com symbols/OMXSTO-AZN/news/AZN performansını etkileyen olaylardan haberdar olmak için en son ASTRAZENECA PLC finans haberlerini ve manşetlerini bulun.
- seekingalpha.com symbol/AZNA high-level overview of AstraZeneca PLC (AZN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- ice.com products/38716781/AstraZeneca-PLCMarket Specifications. Trading Screen Product Name. AstraZeneca plc.
- wallmine.com nyse/aznUPDATE 1-AstraZeneca to buy Amolyt Pharma for $1.05 bln to boost rare-disease portfolio. Filter news. Notable SEC filings of Astrazeneca plc.
- markets.ft.com data/equities/tearsheet/summary…Latest AstraZeneca PLC (AZN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
- bionity.com en/encyclopedia/AstraZeneca.html^ AstraZeneca - History, merger of Astra AB and Zeneca Group PLC, part of the AstraZeneca home site.
- apnews.com hub/astrazeneca-plcAstrazeneca: Q2 Earnings Snapshot. CAMBRIDGE, Britain (AP) _ Astrazeneca PLC (AZN) on Friday reported second-quarter net income of $360 million.
- stocktwits.com symbol/AZN$AZN AstraZeneca completes acquisition of Amolyt Pharma AstraZeneca announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage...